4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-21-049171
Chief Executive Officer bought 2,000 shares at $4.48 ($8,960)
From the SEC's structured data for this filing
Trades in this filing
Gros David-Alexandre C · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-12-20 | Purchase : show line 1 in the form | +2,000 | $4.48 | $8,960 | 9,000 | D |
| Open-market purchases · 2,000 sh · avg $4.48 · $8,960 | ||||||
Loading xslF345X03/doc4.xml…